Endometrial Hemostasis in Normal Menstruation and Heavy Menstrual Bleeding
Seminars in Thrombosis and Hemostasis · 30.10.2026
DOI: 10.1055/a-2988-5951 ↗Kurz gefasst
Fachartikel in der Zeitschrift Seminars in Thrombosis and Hemostasis, online erschienen am 30.10.2026. Verfasst von Rojan Saghian und 1 weiteren Autor:innen. Beteiligte Einrichtung: FAMU-FSU College of Engineering, Department of Chemical and Biomedical Engineering, Florida, United States, Tallahassee. Die Arbeit nennt 135 Literaturangaben. Gefördert von: National Science Foundation, Consortium for Medical Marijuana Clinical Outcomes Research, Eberhard F. Mammen Young Investigator Award.
Abstract (Originalsprache)
Heavy menstrual bleeding (HMB) affects up to one-third of reproductive-age women and remains a major cause of gynecologic consultations and impaired quality of life. While some cases are attributable to structural uterine abnormalities, many occur without identifiable pathology, and the mechanisms regulating menstrual blood loss remain incompletely understood. Emerging evidence suggests that menstrual hemostasis depends on coordinated local vascular and hemostatic processes within the endometrium, including spiral artery remodeling, vasoconstriction, transient hemostatic plug formation, and tightly regulated coagulation and fibrinolysis. Disruption of these mechanisms, through abnormal vessel remodeling, impaired thrombus formation, or excessive fibrinolytic activity, may contribute to excessive bleeding. In this review, we synthesize current evidence on endometrial vascular biology and hemostatic regulation during menstruation and propose a hypothetical, multiphase biomechanical framework, yet to be validated, in which permissive fibrinolysis, nonocclusive coagulation clots, vasoconstriction, and occlusive shear-induced platelet aggregation successively dominate menstrual hemostasis. Within this framework, unexplained HMB is hypothesized to arise when impaired spiral artery vasoconstriction prevents local wall shear from reaching the range that supports mechanically robust, platelet-rich occlusion. Although this proposed framework is intended as a testable hypothesis, it generates specific, falsifiable predictions and identifies measurements needed to evaluate it. By highlighting key knowledge gaps in the control of menstrual hemostasis, this work aims to guide future research toward mechanism-based, fertility-preserving therapies for women with HMB.
Autor:innen und Institutionen
- FAMU-FSU College of Engineering, Department of Chemical and Biomedical Engineering, Florida, United States, Tallahassee.
- Institute for Successful Longevity, Florida State University, Florida, United States, Tallahassee.
ORCID-Profile: Rojan Saghian, Zixiang Leonardo Liu
Förderung
- National Science Foundation
- Consortium for Medical Marijuana Clinical Outcomes Research
- Eberhard F. Mammen Young Investigator Award
Zitieren
APA
Saghian, R., & Liu, Z. L. (2026). Endometrial Hemostasis in Normal Menstruation and Heavy Menstrual Bleeding. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/a-2988-5951
Vancouver
Saghian R, Liu ZL. Endometrial Hemostasis in Normal Menstruation and Heavy Menstrual Bleeding. Seminars in Thrombosis and Hemostasis. 2026. doi:10.1055/a-2988-5951
BibTeX
@article{Saghian2026,
author = {Saghian, Rojan and Liu, Zixiang Leonardo},
title = {Endometrial Hemostasis in Normal Menstruation and Heavy Menstrual Bleeding},
journal = {Seminars in Thrombosis and Hemostasis},
year = {2026},
doi = {10.1055/a-2988-5951}
}
EUVIMED